Position in BNTX
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$78,442,998
-$40,068,339 QoQ
Shares Held
882,572
-29.1% QoQ
Ownership
0.349%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 62.986135975308535.ToString("F0")%
Shared 0.ToString("F0")%
None 37.013864024691465.ToString("F0")%
Common Shares in BNTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BAILLIE GIFFORD & CO holds $3,167,080,960 across 13 Biotechnology names. BNTX ranks #6 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
19,985,876 | $1,015,282,499 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,493,866 | $825,145,441 | |
| 3 | RPRX |
Royalty Pharma plc
|
16,155,677 | $774,987,824 | |
| 4 | DNLI |
Denali Therapeutics Inc.
|
12,066,479 | $231,676,395 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
199,421 | $89,049,452 | |
| 6 | BNTX |
BioNTech SE
This page
|
882,572 | $78,442,998 | |
| 7 | RXRX |
Recursion Pharmaceuticals, Inc.
|
23,675,407 | $72,683,498 | |
| 8 | SANA |
Sana Biotechnology, Inc.
|
6,609,065 | $19,034,107 |
All Filings in BNTX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $78,442,998 | 882,572 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $118,511,337 | 1,244,867 | Shares | Defined | 2026-01-23 | |
| 2025-09-30 | $777,062,382 | 7,879,359 | Shares | Defined | 2025-10-31 | |
| 2025-06-30 | $855,898,700 | 8,038,872 | Shares | Defined | 2025-08-06 | |
| 2025-03-31 | $743,020,642 | 8,159,682 | Shares | Defined | 2025-05-07 | |
| 2024-12-31 | $936,735,203 | 8,220,581 | Shares | Defined | 2025-01-31 | |
| 2024-09-30 | $986,749,589 | 8,308,071 | Shares | Defined | 2024-11-05 | |
| 2024-06-30 | $665,083,305 | 8,276,298 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $771,112,122 | 8,358,939 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $917,056,265 | 8,689,182 | Shares | Defined | 2024-01-26 | |
| 2023-09-30 | $934,612,428 | 8,602,839 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $804,110,661 | 7,450,298 | Shares | Defined | 2023-07-28 | |
| 2023-03-31 | $939,371,406 | 7,540,912 | Shares | Defined | 2023-05-03 | |
| 2022-12-31 | $1,159,416,434 | 7,718,123 | Shares | Defined | 2023-03-10 | |
| 2022-09-30 | $977,215,310 | 7,245,072 | Shares | Defined | 2022-10-27 | |
| 2022-06-30 | $1,082,910,315 | 7,262,980 | Shares | Defined | 2022-08-08 | |
| 2022-03-31 | $1,150,375,518 | 6,744,697 | Shares | Defined | 2022-05-05 | |
| 2021-12-31 | $1,684,061,999 | 6,532,436 | Shares | Defined | 2022-01-20 | |
| 2021-09-30 | $1,732,206,994 | 6,345,313 | Shares | Defined | 2021-10-19 | |
| 2021-06-30 | $1,439,492,204 | 6,429,749 | Shares | Defined | 2021-08-02 | |
| 2021-03-31 | $735,723,528 | 6,738,012 | Shares | Defined | 2021-05-06 | |
| No filing history on record for this holder in this stock. | ||||||